BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 30878400)

  • 1. Modeling Pancreatic Cancer through Somatic Editing with AAV.
    Curiel-GarcÍa A; Olive KP
    Trends Mol Med; 2019 May; 25(5):361-362. PubMed ID: 30878400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pipeline for rapidly generating genetically engineered mouse models of pancreatic cancer using in vivo CRISPR-Cas9-mediated somatic recombination.
    Ideno N; Yamaguchi H; Okumura T; Huang J; Brun MJ; Ho ML; Suh J; Gupta S; Maitra A; Ghosh B
    Lab Invest; 2019 Jul; 99(8):1233-1244. PubMed ID: 30728464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic cancer modeling using retrograde viral vector delivery and in vivo CRISPR/Cas9-mediated somatic genome editing.
    Chiou SH; Winters IP; Wang J; Naranjo S; Dudgeon C; Tamburini FB; Brady JJ; Yang D; Grüner BM; Chuang CH; Caswell DR; Zeng H; Chu P; Kim GE; Carpizo DR; Kim SK; Winslow MM
    Genes Dev; 2015 Jul; 29(14):1576-85. PubMed ID: 26178787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methods for In Vivo CRISPR/Cas Editing of the Adult Murine Retina.
    Hung SS; Li F; Wang JH; King AE; Bui BV; Liu GS; Hewitt AW
    Methods Mol Biol; 2018; 1715():113-133. PubMed ID: 29188510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basic and Clinical Application of Adeno-Associated Virus-Mediated Genome Editing.
    He X; Xie H; Liu X; Gu F
    Hum Gene Ther; 2019 Jun; 30(6):673-681. PubMed ID: 30588843
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Chang YJ; Bae J; Zhao Y; Lee G; Han J; Lee YH; Koo OJ; Seo S; Choi YK; Yeom SC
    J Vet Sci; 2020 Mar; 21(2):e26. PubMed ID: 32233134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standard screening methods underreport AAV-mediated transduction and gene editing.
    Lang JF; Toulmin SA; Brida KL; Eisenlohr LC; Davidson BL
    Nat Commun; 2019 Jul; 10(1):3415. PubMed ID: 31363095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multifunctional AAV-CRISPR-Cas9 and its host response.
    Chew WL; Tabebordbar M; Cheng JK; Mali P; Wu EY; Ng AH; Zhu K; Wagers AJ; Church GM
    Nat Methods; 2016 Oct; 13(10):868-74. PubMed ID: 27595405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient Gene Delivery and Expression in Pancreas and Pancreatic Tumors by Capsid-Optimized AAV8 Vectors.
    Chen M; Maeng K; Nawab A; Francois RA; Bray JK; Reinhard MK; Boye SL; Hauswirth WW; Kaye FJ; Aslanidi G; Srivastava A; Zajac-Kaye M
    Hum Gene Ther Methods; 2017 Feb; 28(1):49-59. PubMed ID: 28125909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining Engineered Nucleases with Adeno-associated Viral Vectors for Therapeutic Gene Editing.
    Epstein BE; Schaffer DV
    Adv Exp Med Biol; 2017; 1016():29-42. PubMed ID: 29130152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AAV Vectorization of DSB-mediated Gene Editing Technologies.
    Moser RJ; Hirsch ML
    Curr Gene Ther; 2016; 16(3):207-19. PubMed ID: 27280971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR-Mediated Integration of Large Gene Cassettes Using AAV Donor Vectors.
    Bak RO; Porteus MH
    Cell Rep; 2017 Jul; 20(3):750-756. PubMed ID: 28723575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR/Cas9-mediated genome engineering: an adeno-associated viral (AAV) vector toolbox.
    Senís E; Fatouros C; Große S; Wiedtke E; Niopek D; Mueller AK; Börner K; Grimm D
    Biotechnol J; 2014 Nov; 9(11):1402-12. PubMed ID: 25186301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Emerging Role of Cyclin-Dependent Kinases (CDKs) in Pancreatic Ductal Adenocarcinoma.
    García-Reyes B; Kretz AL; Ruff JP; von Karstedt S; Hillenbrand A; Knippschild U; Henne-Bruns D; Lemke J
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30340359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The acinar regulator Gata6 suppresses KrasG12V-driven pancreatic tumorigenesis in mice.
    Martinelli P; Madriles F; Cañamero M; Pau EC; Pozo ND; Guerra C; Real FX
    Gut; 2016 Mar; 65(3):476-86. PubMed ID: 25596178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer.
    Lewis BC; Klimstra DS; Varmus HE
    Genes Dev; 2003 Dec; 17(24):3127-38. PubMed ID: 14681205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simplified Purification of AAV and Delivery to the Pancreas by Intraductal Administration.
    Guo P; Wiersch J; Xiao X; Gittes G
    Methods Mol Biol; 2019; 1950():373-387. PubMed ID: 30783986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR/Cas9-mediated genome editing via postnatal administration of AAV vector cures haemophilia B mice.
    Ohmori T; Nagao Y; Mizukami H; Sakata A; Muramatsu SI; Ozawa K; Tominaga SI; Hanazono Y; Nishimura S; Nureki O; Sakata Y
    Sci Rep; 2017 Jun; 7(1):4159. PubMed ID: 28646206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome Engineering Using Adeno-associated Virus: Basic and Clinical Research Applications.
    Gaj T; Epstein BE; Schaffer DV
    Mol Ther; 2016 Mar; 24(3):458-64. PubMed ID: 26373345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclease-free Adeno-Associated Virus-Mediated Il2rg Gene Editing in X-SCID Mice.
    Hiramoto T; Li LB; Funk SE; Hirata RK; Russell DW
    Mol Ther; 2018 May; 26(5):1255-1265. PubMed ID: 29606506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.